Diagnostics News and Research

RSS

Scientists analyze if T-cell tests can be used to determine whether people had COVID-19

Can T-cell tests be used to determine whether people have had COVID-19? Scientists at Uppsala University and Karolinska Institutet have jointly analysed this issue under the aegis of the COMMUNITY study at Danderyd Hospital. Their study is published in the scientific journal PLOS ONE.

4 Oct 2021

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

EKF Diagnostics, the global in vitro diagnostics company, has appointed Luke Daum PhD as Chief Scientific Officer, bringing a wealth of expertise in molecular-based diagnostics to EKF’s leadership team.

From EKF Diagnostics 1 Oct 2021

Research finds possible connection between bacteria and bowel cancer

New research from RCSI University of Medicine and Health Sciences has found a possible relationship between the presence of a specific type of bacteria found in tumors and the spread of bowel cancer.

1 Oct 2021

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

A recent study by a multidisciplinary team of cardiologists and infectious disease specialists at Children's Hospital Colorado (Children's Colorado) found that pediatric patients suffering from Multisystem Inflammatory Syndrome (MIS-C) who received initial, intensified therapy consisting of intravenous immunoglobulin (IVIG) plus Infliximab had improved cardiac outcomes versus those who received IVIG alone.

30 Sep 2021

Virtual care with remote automated monitoring can improve outcomes after non-elective surgery

Patients using take-home technology following non-elective surgery resulted in significantly greater detection and correction of drug errors, and reduction in patients' pain, says a national study led by Hamilton researchers.

30 Sep 2021

New AI-based tool improves the diagnosis of breast cancer tumors

Researchers at Karolinska Institutet in Sweden have developed an AI-based tool that improves the diagnosis of breast cancer tumors and the ability to predict the risk of recurrence.

30 Sep 2021

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.

30 Sep 2021

New facility established for testing innovative health nanotechnologies

A bespoke nationwide facility for testing innovative nanotechnologies for healthcare applications is to be established at the University of Strathclyde.

29 Sep 2021

Hamilton and Rhinostics Reinvent Rapid Swab-Based Sample Workflows from Collection to Processing

Hamilton Company and Rhinostics are combining their respective strengths to improve the speed and quality of nasal and nasopharyngeal sample workflows.

From Hamilton Process Analytics 28 Sep 2021

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).

28 Sep 2021

New discovery greatly improves detection of HPV in the bloodstream

Princess Margaret Cancer Centre researchers have made new findings which greatly improve detection of the human papillomavirus (HPV) in the bloodstream and could further hone precision treatment of the illness.

27 Sep 2021

Researchers develop new method for rapidly detecting SARS-CoV-2 RNA

DTU-researchers develop a novel method for rapidly detecting SARS-CoV-2 RNA that may also be designed to detect other diseases.

27 Sep 2021

New blood test to diagnose Alzheimer's disease using atomic force microscopy

If the suspicion of Alzheimer's disease creeps up, those affected must prepare themselves for lengthy and complex procedures until the case is clear.

27 Sep 2021

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

Global leaders attending the Global COVID-19 Summit hosted by the United States have again underlined their commitment to ensuring equitable access to COVID-19 vaccines for all countries through COVAX – noting that equitable access is essential to end the acute stage of the pandemic.

27 Sep 2021

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

Global leaders attending the US-hosted Global COVID-19 Summit on 22 September re-affirmed their commitment to ending the acute phase of the pandemic, and the goals of the ACT-Accelerator, by agreeing targets to provide equitable access to COVID-19 tests, treatments, and vaccines.

27 Sep 2021

MD Anderson supports World Cancer Research Day and its efforts to promote cancer research

The University of Texas MD Anderson Cancer Center is proud to support World Cancer Research Day, Sept. 24, and its efforts to promote cancer research as a driving force behind progress in cancer prevention, early detection, treatment, and survivorship.

25 Sep 2021

NCI recognizes UC Davis as one of the most elite cancer centers

The National Cancer Institute once again recognized UC Davis Comprehensive Cancer Center as one of the nation's most elite cancer centers, awarding the center $17.5 million over five years and renewing the cancer center's "comprehensive" designation.

24 Sep 2021

New program sets out to change the European landscape for emerging medical radionuclides

The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides.

23 Sep 2021

First UK-manufactured lateral flow devices rolled out to universities across England

The first UK-manufactured rapid tests - otherwise known as lateral flow devices or LFDs - are being rolled out to universities across England.

22 Sep 2021

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

President Joe Biden's failure to name someone to lead the Food and Drug Administration, more than 10 months after the election, has flummoxed public health experts who say it's baffling for the agency to be without a permanent leader during a national health crisis.

22 Sep 2021

Diagnostics News and Research

Scientists analyze if T-cell tests can be used to determine whether people had COVID-19

EKF Diagnostics appoints Luke Daum as Chief Scientific Officer

Research finds possible connection between bacteria and bowel cancer

Dual therapy improves cardiac outcomes in pediatric patients suffering from MIS-C

Virtual care with remote automated monitoring can improve outcomes after non-elective surgery

New AI-based tool improves the diagnosis of breast cancer tumors

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

New facility established for testing innovative health nanotechnologies

Hamilton and Rhinostics Reinvent Rapid Swab-Based Sample Workflows from Collection to Processing

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

New discovery greatly improves detection of HPV in the bloodstream

Researchers develop new method for rapidly detecting SARS-CoV-2 RNA

New blood test to diagnose Alzheimer's disease using atomic force microscopy

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

Global leaders align with the ACT-Accelerator to end COVID-19 pandemic

MD Anderson supports World Cancer Research Day and its efforts to promote cancer research

NCI recognizes UC Davis as one of the most elite cancer centers

New program sets out to change the European landscape for emerging medical radionuclides

First UK-manufactured lateral flow devices rolled out to universities across England

Public health experts ‘flabbergasted’ that Biden still hasn’t picked an FDA chief

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News